222 related articles for article (PubMed ID: 17889711)
1. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
Jara L; Acevedo ML; Blanco R; Castro VG; Bravo T; Gómez F; Waugh E; Peralta O; Cabrera E; Reyes JM; Ampuero S; González-Hormazábal P
Cancer Genet Cytogenet; 2007 Oct; 178(1):65-9. PubMed ID: 17889711
[TBL] [Abstract][Full Text] [Related]
2. Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population.
Jara L; Dubois K; Gaete D; de Mayo T; Ratkevicius N; Bravo T; Margarit S; Blanco R; Gómez F; Waugh E; Peralta O; Reyes JM; Ibáñez G; González-Hormazábal P
Breast Cancer Res Treat; 2010 Aug; 122(3):813-22. PubMed ID: 20054644
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.
Jakubowska A; Narod SA; Goldgar DE; Mierzejewski M; Masojć B; Nej K; Huzarska J; Byrski T; Górski B; Lubiński J
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):457-9. PubMed ID: 12750242
[TBL] [Abstract][Full Text] [Related]
4. CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.
Palanca Suela S; Esteban Cardeñosa E; Barragán González E; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Montalar Salcedo J; Castel Sánchez V; Bolufer Gilabert P;
Breast Cancer Res Treat; 2010 Jan; 119(1):87-93. PubMed ID: 19214744
[TBL] [Abstract][Full Text] [Related]
5. Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer.
Romanowicz-Makowska H; Smolarz B; Kulig A
Pol J Pathol; 2005; 56(4):161-5. PubMed ID: 16477874
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
7. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiñski J; Scott RJ; Hamann U
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):270-5. PubMed ID: 17301259
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.
Vral A; Willems P; Claes K; Poppe B; Perletti G; Thierens H
Mol Med Rep; 2011; 4(5):901-12. PubMed ID: 21725594
[TBL] [Abstract][Full Text] [Related]
9. Variation in the RAD51 gene and familial breast cancer.
Lose F; Lovelock P; Chenevix-Trench G; Mann GJ; Pupo GM; Spurdle AB;
Breast Cancer Res; 2006; 8(3):R26. PubMed ID: 16762046
[TBL] [Abstract][Full Text] [Related]
10. [Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers].
Hu R; Wei Y; Jiang WJ; Yao WX; Long QM; Zhang JH; Liang Y; Tang XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):973-5. PubMed ID: 19253839
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.
Blasiak J; Przybyłowska K; Czechowska A; Zadrozny M; Pertyński T; Rykała J; Kołacińska A; Morawiec Z; Drzewoski J
Acta Biochim Pol; 2003; 50(1):249-53. PubMed ID: 12673366
[TBL] [Abstract][Full Text] [Related]
12. Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer.
Romanowicz-Makowska H; Smolarz B; Zadrozny M; Kulig A
Exp Oncol; 2006 Jun; 28(2):156-9. PubMed ID: 16837909
[TBL] [Abstract][Full Text] [Related]
13. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
Gao LB; Pan XM; Li LJ; Liang WB; Zhu Y; Zhang LS; Wei YG; Tang M; Zhang L
Breast Cancer Res Treat; 2011 Feb; 125(3):827-35. PubMed ID: 20640595
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer.
Krupa R; Synowiec E; Pawlowska E; Morawiec Z; Sobczuk A; Zadrozny M; Wozniak K; Blasiak J
Exp Mol Pathol; 2009 Aug; 87(1):32-5. PubMed ID: 19426727
[TBL] [Abstract][Full Text] [Related]
15. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
[TBL] [Abstract][Full Text] [Related]
16. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population.
Costa S; Pinto D; Pereira D; Rodrigues H; Cameselle-Teijeiro J; Medeiros R; Schmitt F
Breast Cancer Res Treat; 2007 Jun; 103(2):209-17. PubMed ID: 17063276
[TBL] [Abstract][Full Text] [Related]
17. Screening for RAD51 and BRCA2 BRC repeat mutations in breast and ovarian cancer families.
Rapakko K; Heikkinen K; Karppinen SM; Winqvist R
Cancer Lett; 2006 May; 236(1):142-7. PubMed ID: 16005565
[TBL] [Abstract][Full Text] [Related]
18. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
Wang Z; Dong H; Fu Y; Ding H
Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943
[TBL] [Abstract][Full Text] [Related]
19. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients.
Synowiec E; Stefanska J; Morawiec Z; Blasiak J; Wozniak K
Mutat Res; 2008 Dec; 648(1-2):65-72. PubMed ID: 18977234
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
